Acute treatment of migraine attacks: Efficacy and safety of a nonsteroidal anti-inflammatory drug, diclofenac-potassium, in comparison to oral sumatriptan and placebo

Cephalalgia

Volumn 19, Issue 4, 1999, Pages 232-240

  Bussone, G ^a   Grazzi, L ^a   D'Amico, D ^a   Manzoni, C ^b   Granella, F ^b   Cortelli, P ^c   Pierangeli, G ^c   Canal, N ^d   Colombo, B ^d   Frediani, F ^e   Maltempo, C ^e   Peruzzi, E ^f   Edson, Kathryn ^g   Ezzet, N ^g   Huels, J ^g  

^a DEPARTMENT OF NEUROSURGERY   (Italy)

^b UNIVERSITY OF PARMA MEDICAL SCHOOL   (Italy)

^c UNIVERSITY OF BOLOGNA   (Italy)

^d SAN RAFFAELE HOSPITAL   (Italy)

^e Ospedale di Magenta   (Italy)

^f Italy   (Italy)

^g NOVARTIS PHARMA AG   (Switzerland)

Author keywords

Acute treatment; Clinical trial; Diclofenac potassium; Migraine headache; NSAID; Oral treatment; Sumatriptan

Indexed keywords

DICLOFENAC POTASSIUM; NONSTEROID ANTIINFLAMMATORY AGENT; PARACETAMOL; PLACEBO; SUMATRIPTAN;

ABDOMINAL PAIN; ADOLESCENT; ADULT; AGED; ARTICLE; ASTHENIA; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE CLASSIFICATION; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; FATIGUE; FEMALE; HEADACHE; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL SOCIETY; MIGRAINE; MULTICENTER STUDY; NAUSEA; ORAL DRUG ADMINISTRATION; PAIN ASSESSMENT; PARESTHESIA; PHOTOPHOBIA; PRESCRIPTION; RANDOMIZED CONTROLLED TRIAL; SOMNOLENCE; TACHYCARDIA; THORAX PAIN; TREATMENT OUTCOME; VERTIGO; VOMITING;

ADMINISTRATION, ORAL; ADULT; AGED; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; CROSS-OVER STUDIES; DICLOFENAC; DOUBLE-BLIND METHOD; HUMANS; MIDDLE AGED; MIGRAINE DISORDERS; PLACEBOS; SEROTONIN AGONISTS; SUMATRIPTAN; TREATMENT OUTCOME; VASOCONSTRICTOR AGENTS;

EID: 0033043501     PISSN: 03331024     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1468-2982.1999.019004232.x     Document Type: Article

References (21)

1. 1. Lipton RB, Stewart WF, von Korff W. Burden of migraine: societal costs and therapeutic opportunities. Neurology 1997;48 Suppl 3:S4-9
2. 2. Rasmussen BK, Jensen R, Scholl M, Olesen J. Epidemiology of headache in a general population - a prevalence study. J Clin Epidemiol 1991;11:1147-57
3. 3. Leone M, Grazzi L, D'Amico D, Moschiano F, Bussone G, A review of the treatment of primary headaches. Part 1: Migraine. Ital J Neurol Sci 1995;16:577-86
4. 4. Goadsby PJ, Olesen J. Diagnosis and management of migraine. BMJ 1996;312:1279-83
5. 5. Diamond S. Nonsteroidal anti-inflammatory drugs in migraine. In: Lewis AJ, Furst DE, editors. Nonsteroidal anti-inflammatory drugs. New York: Marcel Dekker Inc. 1994:27-42
6. 6. Pfaffenrath V, Scherzer S. Analgesics and NSAIDs in the treatment of the acute migraine attack. Cephalalgia 1995;15 Suppl: 14-20
7. 7. Silberstein SD, Young WB. Safety and efficacy of ergotamine tartrate and dihydroergotamine in the treatment of migraine and status migrainosus. Neurology 1995;45:577-84
8. 8. Lloyd K. The clinical profile of sumatriptan safety and tolerability, Eur Neurol 1994;34 Suppl 2:40-3
9. 9. Ottervanger JP, Van Witsen TB, Valkenburg HA, Grobbee DE, Stricker BH. Adverse reactions attributed to sumatriptan - a postmarketing study in general practice. Eur J Clin Pharmacol 1994;47:305-9
10. 10. Wilkinson M, Pfaffenrath V, Schoenen J, Diener H-C, Steiner TJ. Migraine and cluster headache - their management with sumatriptan: a critical review of the current clinical experience. Cephalalgia 1995;15:337-57
11. 11. Plosker GL, McTavish D. Sumatriptan: a reappraisal of its pharmacology and therapeutic efficacy in the acute treatment of migraine and cluster headache. Drugs 1994;47: 622-51
12. 12. Visser WH, de Vriend RHM, Jaspers NMWH, Ferrari MD. Sumatriptan in clinical practice: a 2-year review of 453 migraine patients. Neurology 1996;47:46-51
13. 13. Bakshi R, et al. A double-blind, placebo-controlled trial comparing the analgesic efficacy of two formulations of diclofenac in postoperative dental pain. Curr Ther Res 1992;52:435-42
14. 14. Todd PA, Sorkin EM. Diclofenac sodium - a reappraisal of its pharmacodynamic and pharmacokinetic properties and therapeutic efficacy. Drugs 1988;35:244-85
15. 15. Dahlöf C, Björkman R. Diclofenac-K (50 and 100 mg) and placebo in the acute treatment of migraine. Cephalalgia 1993;13:117-23
16. 16. Headache Classification Committee of the International Headache Society. Diagnostic criteria: 1. Migraine. Cephalalgia 1988;8 Suppl 7:19-28
17. 17. Kenward MG, Jones B. The analysis of categorical data from cross-over trials using a latent variable model. Stat Med 1991;10:1607-19
18. 18. Tfelt-Hansen P, Henry P, Mulder LJ, Schneidewaert RG, Schoenen J, Chazot G. The effectiveness of combined oral lysine acetylsalicylate and metoclopramide compared with oral sumatriptan for migraine. The Lancet 1995;346:923-6
19. 19. The Oral Sumatriptan and Aspirin plus Metoclopramide Comparative Study Group. A study to compare oral sumatriptan with oral aspirin plus oral metoclopramide in the acute treatment of migraine. Eur Neurol 1992;32:177-84
20. 20. Del Bene E, Poggioni M, Garagiola U, Maresca V. Intramuscular treatment of migraine attacks using diclofenac sodium: a crossover clinical trial. J Int Med Res 1987;15:44-9
21. 21. Karachalios GN, Fotiadou A, Nickolaos C, Karabetsos A, Kehagioglou K. Treatment of acute migraine attack with diclofenac sodium: a double-blind study. Headache 1992;32:98-100